Please note, endo sessions has been updated to remove some site content from past Endocrine Society programs.
If you have any questions please contact [email protected].
Search:
Search for text in:
separate each search
term with a space
term with a space
Multiple terms:
Quick Links:
Additional Search Filters:
Access:
Availability:
Showing session: reset
Lipids and Steroids in Cardiovascular Disease
| Browse by: | Sort by: |
Chair
Jeremy Tomlinson, BA,BM,BCH,MRCP,MD
University of Oxford, Woodstock, United Kingdom
Genome-Wide Meta-Analysis and Mendelian Randomization Identify Early Biomarkers of Non-Alcoholic Fatty Liver Disease
Emilie Gobeil, BSc
Laval University, Quebec City, QC, Canada
Audience Q&A
Both Elafibranor and Liraglutide Improve NAFLD / NASH but Affect Differentially the Hepatic Lipidome and Metabolome in a Diet-Induced Obese and Biopsy-Confirmed Mouse Model of NASH
Konstantinos Stefanakis, MD Student
Beth Israel Deaconess Medical Center, Harvard Medical School; Boston VA Healthcare System, Boston, MA
Audience Q&A
Leptin Improves Cardiac Structure and Function in Patients With Generalized Lipodystrophy
Rebecca Brown, MD
National Institutes of Health, Bethesda, MD
Audience Q&A
The Impact of ACTH on Peripheral Steroids Differs between Unilateral and Bilateral Primary Aldosteronism
Yuta Tezuka, MD, PhD
UNIVERSITY OF MICHIGAN, Ann arbor, MI
Audience Q&A
Available
